Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 Chest Ct Quantification: Triage and Prognostic Value in Different Ages Publisher Pubmed



Nokiani AA1, 2 ; Shahnazari R1, 2 ; Abbasi MA2 ; Divsalar F2 ; Bayazidi M1 ; Sadatnaseri A3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Radiology, Firoozabadi Hospital, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Firoozabadi Clinical Research Development Unit (FCRDU), Iran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Clinical Medicine and Research Published:2023


Abstract

Objective: We evaluated the triage and prognostic performance of seven proposed computed tomography (CT)-severity score (CTSS) systems in two different age groups. Design: Retrospective study. Setting: COVID-19 pandemic. Participants: Admitted COVID-19, PCR-positive patients were included, excluding patients with heart failure and significant pre-existing pulmonary disease. Methods: Patients were divided into two age groups: ≥65 years and ≤64 years. Clinical data indicating disease severity at presentation and at peak disease severity were recorded. Initial CT images were scored by two radiologists according to seven CTSSs (CTSS1-CTSS7). Receiver operating characteristic (ROC) analysis for the performance of each CTSS in diagnosing severe/critical disease on admission (triage performance) and at peak disease severity (prognostic performance) was done for the whole cohort and each age group separately. Results: Included were 96 patients. Intraclass correlation coefficient (ICC) between the two radiologists scoring the CT scan images were good for all the CTSSs (ICC=0.764-0.837). In the whole cohort, all CTSSs showed an unsatisfactory area under the curve (AUC) in the ROC curve for triage, excluding CTSS2 (AUC=0.700), and all CTSSs showed acceptable AUCs for prognostic usage (0.759-0.781). In the older group (≥65 years; n=55), all CTSSs excluding CTSS6 showed excellent AUCs for triage (0.804-0.830), and CTSS6 was acceptable (AUC=0.796); all CTSSs showed excellent or outstanding AUCs for prognostication (0.859-0.919). In the younger group (≤64 years; n=41), all CTSSs showed unsatisfactory AUCs for triage (AUC=0.487-0.565) and prognostic usage (AUC=0.668-0.694), excluding CTSS6, showing marginally acceptable AUC for prognostic performance (0.700). Conclusion: Those CTSSs requiring more numerous segmentations, namely CTSS2, CTSS7, and CTSS5 showed the best ICCs; therefore, they are the best when comparison between two separate scores is needed. Irrespective of patients’ age, CTSSs show minimal value in triage and acceptable prognostic value in COVID-19 patients. CTSS performance is highly variable in different age groups. It is excellent in those aged ≥65 years, but has little if any value in younger patients. Multicenter studies with larger sample size to evaluate results of this study should be conducted. © 2023 Marshfield Clinic Health System.
Other Related Docs
28. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
33. Findings of Serial Computed Tomography Imaging in Patients With Coronavirus Disease-19, Open Access Macedonian Journal of Medical Sciences (2020)
34. Sars-Cov-2; What We Know so Far, Archives of Iranian Medicine (2020)
39. Segmentation of Covid-19 Pneumonia Lesions: A Deep Learning Approach, Medical Journal of the Islamic Republic of Iran (2020)